Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Change in Intangibles: 2016-2020

Historic Change in Intangibles for Collegium Pharmaceutical (COLL) over the last 3 years, with Dec 2020 value amounting to $368.2 million.

  • Collegium Pharmaceutical's Change in Intangibles was N/A to $1.4 million in Q2 2020 from the same period last year, while for Jun 2020 it was $387.1 million, marking a year-over-year change of. This contributed to the annual value of $368.2 million for FY2020, which is N/A change from last year.
  • As of FY2020, Collegium Pharmaceutical's Change in Intangibles stood at $368.2 million, which was up 1,850.66% from $18.9 million recorded in FY2018.
  • In the past 5 years, Collegium Pharmaceutical's Change in Intangibles registered a high of $368.2 million during FY2020, and its lowest value of $2.5 million during FY2016.
  • For the 2-year period, Collegium Pharmaceutical's Change in Intangibles averaged around $193.6 million, with its median value being $193.6 million (2018).